Royce & Associates’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9M Buy
912,492
+4,774
+0.5% +$172K 0.31% 77
2026
Q1
$29.2M Buy
907,718
+161,484
+22% +$5.94M 0.29% 92
2025
Q4
$28.6M Sell
746,234
-1,112,836
-60% -$24.4M 0.29% 91
2025
Q3
$25.5M Buy
1,859,070
+806,446
+77% +$9.46M 0.25% 119
2025
Q2
$13.6M Buy
1,052,624
+132,609
+14% +$1.38M 0.14% 224
2025
Q1
$10.3M Buy
920,015
+1,592
+0.2% +$20.9K 0.11% 275
2024
Q4
$12M Buy
918,423
+453,225
+97% +$11.6M 0.11% 270
2024
Q3
$18.6M Buy
465,198
+10,002
+2% +$364K 0.17% 174
2024
Q2
$13.4M Buy
+455,196
New +$12.4M 0.13% 235

Other funds holding PACS

Royce & Associates's PACS Position: Q2 2026 in Review

Royce & Associates increased its PACS Group (PACS) stake by 0.53% in Q2 2026, buying an estimated $172K and bringing the position to 912,492 shares worth $38.9M. The position accounts for 0.31% of the portfolio, ranked #77.

Royce & Associates first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Royce & Associates held 912,492 shares of PACS Group worth $38.9M as of Q2 2026.
  • Royce & Associates bought 4,774 PACS Group shares in Q2 2026, an estimated $172K.
  • PACS Group made up 0.31% of Royce & Associates's portfolio in Q2 2026, its #77 holding.
  • Royce & Associates first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.